May 14, 2019 / 08:00PM GMT
Tazeen Ahmad - BofA Merrill Lynch, Research Division - VP
Thanks for joining us here at Bank of America Merrill Lynch Conference. I am Tazeen Ahmad, the senior SMid biotech analyst here. Our next presenting company is Amicus Therapeutics. Sitting next to me from Amicus is Brad Campbell, Chief Operating Officer and President. We also have a couple of members of the management team in the audience today as well.
So thank you, Brad, for coming and presenting. For those people who aren't as familiar with the details of Amicus, maybe you can spend a couple of minutes just telling us about the company, your commercial products so far and maybe just a summary of what you've got going on in the pipeline?
Bradley L. Campbell - Amicus Therapeutics, Inc. - President, COO & Director
Sure. Yes. First, thanks, Tazeen, for having us here, and thanks to Bank of America Merrill Lynch for hosting us. Always a great conference for us every year. So we really appreciate the time.
For those of you who aren't totally familiar, Amicus Therapeutics is a global
Amicus Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers